Viral Peptides

InformationKIN1148 KIN1148 is an agonist of interferon regulatory factor 3 (IRF3) that induces dose-dependent IRF3 nuclear translocation and specific activation of IRF3-responsive promoters. KIN1148 is an influenza vaccine adjuvant that enhances flu

InformationKIN1148 KIN1148 is an agonist of interferon regulatory factor 3 (IRF3) that induces dose-dependent IRF3 nuclear translocation and specific activation of IRF3-responsive promoters. KIN1148 is an influenza vaccine adjuvant that enhances flu

Biochem/physiol Actions KIN1400 is innate immune agonists of IRF3 activation that induces IRF3 and MAVS dependent innate immune antiviral genes and IFN&#946: expression. KIN1400 is a broad spectrum antiviral compound that suppresses replication

Biochem/physiol Actions KIN1400 is innate immune agonists of IRF3 activation that induces IRF3 and MAVS dependent innate immune antiviral genes and IFN&#946: expression. KIN1400 is a broad spectrum antiviral compound that suppresses replication

KIN1408 is an agonist of the RIG-1-like receptor (RLR) pathway and exhibits a broad-spectrum antiviral activity. KIN1408 exhibits activity against HCV , influenza A , dengue virus 2 , Ebola , Nipah , and Lassa viruses.In VitroKIN1408 has the potency

KIN1408 is an agonist of the RIG-1-like receptor (RLR) pathway and exhibits a broad-spectrum antiviral activity. KIN1408 exhibits activity against HCV , influenza A , dengue virus 2 , Ebola , Nipah , and Lassa viruses.In VitroKIN1408 has the potency

KIN1408 is an agonist of the RIG-1-like receptor (RLR) pathway and exhibits a broad-spectrum antiviral activity. KIN1408 exhibits activity against HCV , influenza A , dengue virus 2 , Ebola , Nipah , and Lassa viruses.In VitroKIN1408 has the potency

KIN1408 is an agonist of the RIG-1-like receptor (RLR) pathway and exhibits a broad-spectrum antiviral activity. KIN1408 exhibits activity against HCV , influenza A , dengue virus 2 , Ebola , Nipah , and Lassa viruses.In VitroKIN1408 has the potency

KIN1408 is an agonist of the RIG-1-like receptor (RLR) pathway and exhibits a broad-spectrum antiviral activity. KIN1408 exhibits activity against HCV , influenza A , dengue virus 2 , Ebola , Nipah , and Lassa viruses.In VitroKIN1408 has the potency

Application Pulsed Stable Isotope labeling of amino acid has been used to study host-cell function, survival, the precise intracellular pathways in protein synthesis of HIV-1 infected human monocytederived macrophages. Identification of viral

Application Pulsed Stable Isotope labeling of amino acid has been used to study host-cell function, survival, the precise intracellular pathways in protein synthesis of HIV-1 infected human monocytederived macrophages. Identification of viral

DescriptionUsed in the methodology of stable isotope tagging of epitopes (SITE) for identification of virus-induced peptides in vaccine development.